242 related articles for article (PubMed ID: 29661866)
1. Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/β-Klotho System.
Moure R; Domingo P; Villarroya J; Gasa L; Gallego-Escuredo JM; Quesada-López T; Morón-Ros S; Maroto AF; Mateo GM; Domingo JC; Villarroya F; Giralt M
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29661866
[TBL] [Abstract][Full Text] [Related]
2. Levels of β-klotho determine the thermogenic responsiveness of adipose tissues: involvement of the autocrine action of FGF21.
Moure R; Cairó M; Morón-Ros S; Quesada-López T; Campderrós L; Cereijo R; Hernáez A; Villarroya F; Giralt M
Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E822-E834. PubMed ID: 33615874
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of antiretroviral drugs against Plasmodium falciparum.
Nsanzabana C; Rosenthal PJ
Antimicrob Agents Chemother; 2011 Nov; 55(11):5073-7. PubMed ID: 21876053
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice.
Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE
Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733
[TBL] [Abstract][Full Text] [Related]
5. Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients.
Gallego-Escuredo JM; Domingo P; Gutiérrez Mdel M; Mateo MG; Cabeza MC; Fontanet A; Vidal F; Domingo JC; Giralt M; Villarroya F
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):527-34. PubMed ID: 23187887
[TBL] [Abstract][Full Text] [Related]
6. ER stress in human hepatic cells treated with Efavirenz: mitochondria again.
Apostolova N; Gomez-Sucerquia LJ; Alegre F; Funes HA; Victor VM; Barrachina MD; Blas-Garcia A; Esplugues JV
J Hepatol; 2013 Oct; 59(4):780-9. PubMed ID: 23792026
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum stress induces up-regulation of hepatic β-Klotho expression through ATF4 signaling pathway.
Dong K; Li H; Zhang M; Jiang S; Chen S; Zhou J; Dai Z; Fang Q; Jia W
Biochem Biophys Res Commun; 2015 Apr; 459(2):300-305. PubMed ID: 25727012
[TBL] [Abstract][Full Text] [Related]
9. Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir.
Rojas J; Lonca M; Imaz A; Estrada V; Asensi V; Miralles C; Domingo P; Montero M; del Rio L; Fontdevila J; Perez I; Cruceta A; Gatell JM; Arnedo M; Martínez E
HIV Med; 2016 May; 17(5):340-9. PubMed ID: 27089862
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study.
Molina JM; Lamarca A; Andrade-Villanueva J; Clotet B; Clumeck N; Liu YP; Zhong L; Margot N; Cheng AK; Chuck SL;
Lancet Infect Dis; 2012 Jan; 12(1):27-35. PubMed ID: 22015077
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients.
Hsu A; Isaacson J; Brun S; Bernstein B; Lam W; Bertz R; Foit C; Rynkiewicz K; Richards B; King M; Rode R; Kempf DJ; Granneman GR; Sun E
Antimicrob Agents Chemother; 2003 Jan; 47(1):350-9. PubMed ID: 12499212
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 21 is induced by endoplasmic reticulum stress.
Schaap FG; Kremer AE; Lamers WH; Jansen PL; Gaemers IC
Biochimie; 2013 Apr; 95(4):692-9. PubMed ID: 23123503
[TBL] [Abstract][Full Text] [Related]
13. Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho.
Aaldijk AS; Verzijl CRC; Jonker JW; Struik D
Front Endocrinol (Lausanne); 2023; 14():1150222. PubMed ID: 37260446
[TBL] [Abstract][Full Text] [Related]
14. Lipid metabolism and lipodystrophy in HIV-1-infected patients: the role played by nonnucleoside reverse transcriptase inhibitors.
Sension M; Deckx H
AIDS Rev; 2015; 17(1):21-36. PubMed ID: 25472015
[TBL] [Abstract][Full Text] [Related]
15. HIV nucleoside reverse transcriptase inhibitors efavirenz and tenofovir change the growth and differentiation of primary gingival epithelium.
Mitchell D; Israr M; Alam S; Dinello D; Kishel J; Jia R; Meyers C
HIV Med; 2014 Apr; 15(4):196-202. PubMed ID: 24580719
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress.
Kim SH; Kim KH; Kim HK; Kim MJ; Back SH; Konishi M; Itoh N; Lee MS
Diabetologia; 2015 Apr; 58(4):809-18. PubMed ID: 25537833
[TBL] [Abstract][Full Text] [Related]
17. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
Boyd MA; Amin J; Mallon PW; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA;
Lancet HIV; 2017 Jan; 4(1):e13-e20. PubMed ID: 27815068
[TBL] [Abstract][Full Text] [Related]
18. [Role of the new molecules in antiretroviral therapy. Position of raltegravir].
Arribas JR
Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():53-9. PubMed ID: 19572427
[TBL] [Abstract][Full Text] [Related]
19. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds.
Pérez-Martí A; Sandoval V; Marrero PF; Haro D; Relat J
Horm Mol Biol Clin Investig; 2016 Sep; 30(1):. PubMed ID: 27583468
[TBL] [Abstract][Full Text] [Related]
20. Prevention of HIV protease inhibitor-induced dysregulation of hepatic lipid metabolism by raltegravir via endoplasmic reticulum stress signaling pathways.
Cao R; Hu Y; Wang Y; Gurley EC; Studer EJ; Wang X; Hylemon PB; Pandak WM; Sanyal AJ; Zhang L; Zhou H
J Pharmacol Exp Ther; 2010 Aug; 334(2):530-9. PubMed ID: 20472667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
